Status:
RECRUITING
Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
Lead Sponsor:
University of Luebeck
Collaborating Sponsors:
University Hopsital Schleswig Holstein Campus Lübeck
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic...
Eligibility Criteria
Inclusion
- Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement
- BMI \<35 kg/m2
- Ability to give informed consent
Exclusion
- History of coronary artery bypass graft and a patent left internal mammary artery (LIMA)
- Age ≤18 years
- Patients presenting with pregnancy
- Patients without informed consent
- Expected life expectancy \<2 years
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06493994
Start Date
January 1 2025
End Date
January 30 2027
Last Update
January 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universität zu Lübeck
Lübeck, Schleswig-Holstein, Germany, 23538